miR-22, a microRNA that is associated with oncogenic signaling and overexpressed in high-grade breast tumors with poor clinical outcomes26,34,35, directly targets TET family members, including TET2, which in turn leads to hypermethylation of the mir-200 promoter and induction of breast cancer stemness phenotype and metastasis34. This evidence concerns the gene TET2 and breast carcinoma.